A diabetes drug can help save millions of kidney patients



[ad_1]

date-bind-html-content-type = "article" date-bind-html-compile = "article.body" date-first-article-body =

According to a newspaper reported "Daily Mail" British, the study tested a drug "Infocana" for diabetes, the company Janssen The results were discussed Tuesday at a medical meeting in Australia.

In the study, about 13,000 people were Diabetes Type 2 diseases Kidneys Chronic pills worldwide "Invokana".

Observers found that 4,400 people were treated after a treatment of two and a half years on average, which means that the drug clearly helps in the treatment of kidney disease.

The researchers found that people who took the drug were 30 percent less likely to have kidney failure or need for DialysisOr kidney related death Heart.

"The results were dramatic, but the importance of this study can not be overestimated until after further testing and research into new patients," said Dr. Julie Engelfinger.

The drug costs about $ 500 a month U.SBut eventually it depends on the insurance companies.

About 30 million Americans and more than 420 million people worldwide suffer from diabetes, most of them type 2, linked to obesity.

">

According to the British Daily Mail, the study tested the drug "Infokana" drug, drug Jansen, noting that the results were discussed the first Tuesday at a medical meeting in Australia.

In the study, about 13,000 people with type 2 diabetes and chronic kidney disease from around the world received "Invokana" tablets.

Observers found that 4,400 people were treated after a treatment of two and a half years on average, which means that the drug clearly helps in the treatment of kidney disease.

The researchers found that people who took the drug had a 30% lower risk of kidney failure, dialysis or death associated with kidney or heart disease.

"The results were exciting, but the importance of this study can not be overestimated until further testing and research into new patients," said Dr. Julie Engelfinger.

The drug costs about $ 500 a month in the United States, but depends on insurance companies.

About 30 million Americans and more than 420 million people worldwide suffer from diabetes, most of them type 2, linked to obesity.

[ad_2]

Source link